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Spontaneous intracerebral haemorrhage carries a high mortality rate and treatment
of the disease raises more questions then answers. Mass effect, ischaemia and tox-
icity of blood components are responsible for brain tissue damage. Initially occur-
ring disturbances of cerebral blood flow have a temporary character and do not
play a key role in the pathology of intracerebral haematoma. Oedema formatting in
the 24–48 hours after intracerebral bleeding is the result of multidirectional pro-
cesses. The pathological mechanism that underlines it is the function of activation of
systemic complement and cascade of coagulation. In the light of these findings,
further clinical and experimental investigations should be focused on these factors.
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INTRODUCTION
Spontaneous intracerebral haemorrhage (ICH)
is the most destructive type of stroke [3]. ICH com-
monly occurs in the cerebral lobes, basal ganglia,
thalamus, brain stem (predominantly in the pons)
and cerebellum [5]. Perforation into ventricles de-
velops in association with deep large haemato-
mas [14].
Potential pathophysiological and pathochemical
mechanisms that may be involved in ICH include me-
chanical trauma, mass effect and ischaemia, toxicity
of blood components and excitotoxicity [25, 45].
Better understanding of the character and dynam-
ics of the morphological, biochemical changes in-
volved, with emphasis on those taking place within
the perihaematomal zone, can provide a basis for
the development of a more effective therapeutic
strategy. The purpose of this study was to review
recently published investigations into this problem.
As a result of ICH, serious impairment of the in-
tracranial homeostasis develops. Primary injury af-
ter ICH is a result of the mass effect of the haemato-
ma, causing local compression of the microvascula-
ture and leading to disturbances of the cerebral blood
flow (CBF) [23, 26]. Experiments have shown that
perihaematomal CBF falls below 25 mL/100 g min
but that the reduction lasts less than 10 min; CBF
then returns to baseline within 3 h [25, 45]. Mass
effect in the area of the caudate nucleus leads to
disturbance of regional CBF not only in the lesioned
region but also in the frontal cortex overlying the
lesion [33].
According to Qureshi et al. [30], the ischaemic
penumbra is not present around the clot in canine
ICH investigation. It has been established that the
CBF threshold for ischaemic injury is 15 mL/100 g
min [41]. Wagner et al. [37] reported that the ATP
level remained within the normal range, whereas
brain phosphocreatine contents increased with time
in the perihaematomal zone at 1, 3, 5 and 8 h after
ICH. Most recently, Zazulia et al. [47] found that both
CBF and the cerebral metabolic ratio of oxygen were
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reduced in the perihaematomal region, resulting in
a reduced oxygen extraction fraction. These results
indicate that energy deficit was not present around
the haemorrhagic focus.
Secondary damage is thought to be caused by
tissue reaction to the invasion of the products of
blood breakdown in the perihaematomal region,
initiating the formation of brain oedema [13, 19, 39].
Within the first 8 h of onset, this oedema is trig-
gered by the accumulation of osmotically active sub-
stances and the movement of water across an intact
blood-brain barrier (BBB) into the extracellular space [37].
The increase in the number of brain ions such as
sodium and chloride accounts for most of the os-
molar force driving water into the brain [37, 45].
Over the next 24 to 48 hours activation of the coag-
ulation cascade and the induction of proteolytic en-
zymes leads to an inflammatory response, resulting
in BBB disruption [20, 40].
Haemorrhage into brain tissue activates the co-
agulation cascade that produces a large amount of
thrombin during the first day after ICH [19]. It is es-
tablished that infusion of thrombin produces the
same grade of increase in BBB permeability that is
observed in intracerebral haematoma [20]. Inactiva-
tion of thrombin by antithrombin III and other plas-
ma inhibitors limits brain oedema [20]. The specific
mechanism of thrombin action that leads to disrup-
tion of the BBB is suggested by De Michele et al. [7]
and Malik and Fenton [21]. According to these au-
thors, direct modulation of endothelial cell perme-
ability leads to the opening of the BBB.
Developing a few days later, red blood cell (RBC)
lysis plays an important role in brain oedema fol-
lowing ICH [39, 40, 44]. Infusion of lysed RBCs evokes
a 300% increase in BBB permeability compared with
the 50% increase caused by the infusion of 5 U of
thrombin [20]. One potential factor of erythrocyte
lysis is the complement system. As a result of com-
plement cascade activation, complement factors
C5b, C6-C9 form a membrane attack complex
(MAC), which is able to attach to the cell membrane
forming a transmembrane pore that may cause cell
lysis [12]. On an electron microscopy image MAC is
seen as a ring-like structure on the erythrocyte mem-
brane [4]. It is known that MAC occurs in neurons,
causing necrosis, and destroys endothelial cells,
leading to BBB leakage [41]. Limiting brain oede-
ma in the course of ICH by the inhibition of com-
plement using cobra venom factor indicates that
systemic complement plays a key role in ICH-induced
oedema [42].
Haemoglobin breakdown results in a release of
the iron and bilirubin that cause the formation of
brain oedema within 24 h [13]. A lipid peroxydation
evoked by iron may contribute to BBB injury through
free radical damage to the endothelial cells [40].
Reports in recent years indicate that evacuation
of the clot, formerly liquefied by tissue plasminogen
activator (t-PA), markedly decreases the degree of
cerebral oedema and BBB disruption and improves
cerebral perfusion pressure [38]. On the other hand,
Rohde et al. [31] discovered that t-PA employed dur-
ing evacuation of the haematoma results in an in-
crease in oedema volume. The inhibitor of tissue plas-
minogen activator (PAI-1) suppresses both t-PA and
thrombin [31]. By application of t-PA and an increase
in its concentration, inhibition of PAI-1 production
is observed with the effect of decreased thrombin
inhibition. The role of thrombin in oedema format-
ting in the course of ICH has been discussed above.
The astroglial and microglial cells, which are sen-
sitive markers of changes in the cellular microenvi-
ronment of the central nervous system, are impor-
tant factors in the processes which take place when
ICH leads to injury of the nervous tissue [27]. How-
ever, in the first hour after ICH the expression of
proinflammatory cytokines TNF-a, IL-1b, and IL-6 does
not produce any significant changes [29].
In resting form astrocytes have small round cell
bodies with long slim processes (Fig. 1A). Following
brain injury after ICH the cell bodies of astrocytes
become markedly enlarged, and their processes be-
come short and thick (Fig. 1B). This activation of as-
troglial cells is likely to be mediated by signals from
damaged neurons and induced by subtle changes in
the extracellular milieu.
In resting (ramified) form microglial cells are high-
ly branched, usually having between two and six
primary branches that radiate from the soma and
that have many thin protrusions, which extend from
the primary branches (Fig. 1C). During the early phase
of ICH the microglial cells undergo morphological
and metabolic changes towards an activated form;
they retract their processes and become pseudopodic
(Fig. 1D). Their branches typically recede at a rate of
0.5–1.5 µm/min [34]. The achievement of an amoe-
boid form by the microglial cells (Fig. 1E) is preced-
ed by absorption of the tips of the retracting pro-
cesses by the cell body. These changes are accom-
panied by the upregulation of the expression of re-
ceptor complement 3, major histocompatibility
complex class I and inducible nitric oxide synthase
[27, 35, 36, 46].
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Figure 1. Types of glial cells. A. Resting form of astrocyte; B. Activated form of astrocyte; C. Resting form of microglia; D. Activated
form of microglia; E. Amoeboid form of microglia. Scale bar = 25 µm.
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The acute phase is reached within the first day
of injury and is determined by events such as neu-
ronal degeneration, disruption of the BBB and leu-
kocyte extravasation, which trigger important
changes in glial cell morphology toward fully re-
active forms and metabolically activated cells.
These cytoskeletal changes are also accompanied
by phagocytic activation [32]. Moreover, during
this stage astrocytes proliferate and migrate, con-
tributing to restoration of the structural integrity
of the tissue. A recently published outcome of lab-
oratory studies has revealed that astrocytes dem-
onstrate the morphological features of activation
on the third day after ICH and that these remain
for the following three weeks [17]. After damage
reactive astrocytes maintain the activation nucle-
ar factor kB (NF-kB). Focal perivascular activation
of the NF-kB was seen as early as 2 h after ICH,
while more widespread perilesional activation was
observed at 8 h [10]. The peak increase in the level
of protein subunits of NF-kB was observed around
the haemorrhagic focus 4 days after ICH [10].
Activated astrocytic cells synthesise and secrete
TNF-a, IL-1b and IL-6 [1, 2, 6].
During the acute phase the presence of neuronal
debris, massive tissue disruption and BBB breakdown
induces brain microglial cells to become phagocytic
cells [34], showing MHC class II expression and up-
regulation of TNF-a, IL-1b [28]. Activated microglial
cell are able to move at a speed of 118 µm per hour [34].
Kowiański et al. [18] pointed out the marked activa-
tion of microglial-macrophage lineage cells starting
during the first day after ICH.
Intracerebral administration of IL-1b increases
the water content in the brain [9]. It has been shown
that administration of TNF-a induces the BBB to
open in vivo [24]. Holmin and Mathiesen [11] ob-
served that IL-1b caused vasogenic oedema that was
transient within 72 h, whereas TNF-a caused a less
pronounced but more long-lasting vasogenic oede-
ma. Peroxynitrite, which forms by reacting nitric
oxide with superoxide, and high concentration cy-
tokines (IL-1b, TNF-a) activate matrix metallopro-
teinases (MMPs) [43]. Activated MMPs are able to
proteolyse the components of the tight adherent
junction (occludins, cadherins, claudins) [43]. The
result of these changes is increased endothelial per-
meability. A recently published clinical investigation
demonstrates that a high concentration of cytok-
ines, MMPs and products of the degradation of
basal membrane components are associated with
the early stage of ICH [32].
Clinical investigation supports the occurrence of
a late progression of oedema in the third week after
ICH [48]. According to the authors, new vessels
around the haematoma, developing between the
second and third weeks, lack a complete BBB and
are responsible for this phenomenon.
The formation of gliotic tissue, the so-called glial
scar, is the result of the repair response of the glia.
The glial scar is composed of hypertrophied astro-
cytic processes, macrophages and extracellular ma-
trix [1, 27]. Some reactive astroglial cells of the glial
scar contain NF-kB in their nuclei and express IL-1b,
IL-6 and TNF-a [1, 2, 6, 27]. In addition, they modu-
late their own activation by expressing transform-
ing growth factor b1 (TGF-b1) [15]. Furthermore, this
factor increases the expression of several collagen
types (fibronectin, tenascin, thrombospondin) and
promotes the synthesis of protease inhibitors, pro-
viding a reinforcement of glial scar formation [22].
Macrophages play an important role in format-
ting glial scar. These derive from endogenous mi-
croglial cells and express IL-1b and secrete TGF-b1,
undergoing reduction with time [2].
As a result of apoptosis, the number of micro-
glial cells in the glial scar undergoes a gradual re-
duction. A recently published study has shown DNA
fragmentation observed in the clot as well as in the
region surrounding the clot during 3 weeks of ob-
servation [16]. Gong et al. [8] observed TUNEL-pos-
itive cells over a period of 14 days after ICH. Most of
them were neurons, while some were astrocytes or
endothelial cells. This leads to the conclusion that
neurons are more vulnerable than astrocytes or en-
dothelial cells in the course of ICH.
In summary, the pathological processes involved
in ICH have a multidirectional and multidimensional
character. At the beginning they destruct and than
try to restore the structural and functional integrity
of the nervous tissue. It seems that the initially oc-
curring reduction in CBF does not play an important
role. The results of the investigations presented sug-
gest that the therapeutic option should be concen-
trated on the early stages of ICH, before the activa-
tion of NF-kB and the expression of inflammatory
substances. Early evacuation of the haematoma,
within the first few hours of haemorrhage, should
be taken into consideration. Future studies in this
domain will reveal new insights into the pathophys-
iological links between disturbances of the CBF, the
products of blood decomposition and secreted cy-
tokines and should provide new clues for the treat-
ment of these complex diseases.
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